chr7-140808351-CAA-C

Variant summary

Our verdict is . The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1

The NM_004333.6(BRAF):​c.609-291_609-290delTT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.098 in 192,102 control chromosomes in the GnomAD database, including 57 homozygotes. Variant has been reported in ClinVar as Benign (★). The gene BRAF is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.052 ( 57 hom., cov: 21)
Exomes 𝑓: 0.11 ( 0 hom. )

Consequence

BRAF
NM_004333.6 intron

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.450

Publications

1 publications found
Variant links:
Genes affected
BRAF (HGNC:1097): (B-Raf proto-oncogene, serine/threonine kinase) This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome. [provided by RefSeq, Aug 2017]
BRAF Gene-Disease associations (from GenCC):
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • cardiofaciocutaneous syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, Ambry Genetics, PanelApp Australia
  • LEOPARD syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, PanelApp Australia
  • Noonan syndrome 7
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, Ambry Genetics, PanelApp Australia
  • large congenital melanocytic nevus
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • Noonan syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen
  • anaplastic astrocytoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004333.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP6
Variant 7-140808351-CAA-C is Benign according to our data. Variant chr7-140808351-CAA-C is described in ClinVar as Benign. ClinVar VariationId is 1280023.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.137 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004333.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAF
NM_001374258.1
MANE Plus Clinical
c.609-291_609-290delTT
intron
N/ANP_001361187.1A0A2R8Y8E0
BRAF
NM_004333.6
MANE Select
c.609-291_609-290delTT
intron
N/ANP_004324.2
BRAF
NM_001374244.1
c.609-291_609-290delTT
intron
N/ANP_001361173.1A0A2U3TZI2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAF
ENST00000644969.2
MANE Plus Clinical
c.609-291_609-290delTT
intron
N/AENSP00000496776.1A0A2R8Y8E0
BRAF
ENST00000646891.2
MANE Select
c.609-291_609-290delTT
intron
N/AENSP00000493543.1P15056
BRAF
ENST00000288602.11
TSL:1
c.609-291_609-290delTT
intron
N/AENSP00000288602.7A0A2U3TZI2

Frequencies

GnomAD3 genomes
AF:
0.0516
AC:
2167
AN:
42026
Hom.:
56
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.142
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0246
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00393
Gnomad SAS
AF:
0.0549
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0204
Gnomad NFE
AF:
0.00190
Gnomad OTH
AF:
0.0406
GnomAD2 exomes
AF:
0.0963
AC:
2210
AN:
22952
AF XY:
0.0885
show subpopulations
Gnomad AFR exome
AF:
0.141
Gnomad AMR exome
AF:
0.130
Gnomad ASJ exome
AF:
0.0588
Gnomad EAS exome
AF:
0.133
Gnomad FIN exome
AF:
0.0680
Gnomad NFE exome
AF:
0.0816
Gnomad OTH exome
AF:
0.102
GnomAD4 exome
AF:
0.111
AC:
16654
AN:
150088
Hom.:
0
AF XY:
0.110
AC XY:
9704
AN XY:
88134
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.127
AC:
367
AN:
2890
American (AMR)
AF:
0.110
AC:
800
AN:
7292
Ashkenazi Jewish (ASJ)
AF:
0.0822
AC:
341
AN:
4150
East Asian (EAS)
AF:
0.102
AC:
492
AN:
4800
South Asian (SAS)
AF:
0.110
AC:
3131
AN:
28462
European-Finnish (FIN)
AF:
0.116
AC:
750
AN:
6490
Middle Eastern (MID)
AF:
0.0956
AC:
56
AN:
586
European-Non Finnish (NFE)
AF:
0.112
AC:
9937
AN:
88486
Other (OTH)
AF:
0.113
AC:
780
AN:
6932
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.327
Heterozygous variant carriers
0
1074
2148
3223
4297
5371
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0517
AC:
2172
AN:
42014
Hom.:
57
Cov.:
21
AF XY:
0.0517
AC XY:
1017
AN XY:
19676
show subpopulations
African (AFR)
AF:
0.142
AC:
1952
AN:
13760
American (AMR)
AF:
0.0246
AC:
80
AN:
3254
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1250
East Asian (EAS)
AF:
0.00394
AC:
5
AN:
1268
South Asian (SAS)
AF:
0.0547
AC:
74
AN:
1354
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
1270
Middle Eastern (MID)
AF:
0.0213
AC:
2
AN:
94
European-Non Finnish (NFE)
AF:
0.00190
AC:
36
AN:
18956
Other (OTH)
AF:
0.0421
AC:
23
AN:
546
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
76
152
228
304
380
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.45
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.